Two New Glaucoma Medications to Enter Market in Early 2018

Jan 25, 2018

Credit Eye Associates of Lancaster Ltd

For the first time in more than 20 years, there have been some significant medical breakthroughs for the treatment of Glaucoma.  Today’s commonly used glaucoma medications were approved in the 1970s. Other medications with different chemical compounds followed, but until now, there had been no major medical breakthrough since 1998. With the FDA approval of two new medications, Aerie Pharmaceutical’s Rhopressa and Bausch + Lomb/Nicox’s Vyzulta, 2018 promises to usher in a new era for glaucoma treatments.  Learn more about them from the American Foundation for the Blind.